OSR Holdings Unveils $50M Security Token Offering Roadmap Under Reg D, Partners with BCM Europe AG

BELLEVUE, Wash. and ZUG, Switzerland, July 9, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global leader in healthcare innovation, has announced a strategic roadmap for a $50 million Security Token Offering (STO) set to launch in the latter half of 2025. This initiative, operating under Regulation D of the U.S. Securities Act, introduces the OSRT token, a digital asset representing equity exposure in OSR Holdings, as part of the company's blockchain-driven capital strategy. The STO will accept subscriptions in Bitcoin (BTC), Tether (USDT), and Taekwondo Access Credit (TAC), a utility token with growing adoption in the global Taekwondo community. TAC's inclusion highlights its potential utility in blood glucose monitoring devices, with further details to be disclosed in an upcoming announcement. BCM Europe AG, the issuer of TAC and a major OSRH shareholder, will convert its TAC holdings into BTC or USDT prior to participation to ensure compliance and avoid insider trading concerns. OSRH's CEO, Peter Hwang, emphasized the STO's role in the company's long-term capital strategy, alongside an $80 million Equity Line of Credit (ELOC) from White Lion GBM Innovation Fund, aiming to establish a $100 million reserve in Bitcoin and USDT. The roadmap outlines key elements including the $50 million STO target, eligibility of BTC, USDT, and TAC for subscriptions, special restrictions for BCM Europe AG, and the integration of decentralized finance with healthcare innovation. CFO Chris Bang highlighted the offering's potential to attract a new generation of investors while adhering to regulatory standards. OSR Holdings is committed to advancing healthcare through biomedical innovation, with subsidiaries in immuno-oncology, regenerative biologics, and medical device distribution. BCM Europe AG, based in Zug, Switzerland, focuses on healthcare and blockchain investments, notably through the TAC token. The press release contains forward-looking statements subject to risks and uncertainties, including regulatory approvals and market conditions. The OSRT offering awaits final approval from OSR Holdings' Board, contingent on meeting all legal and regulatory requirements.